Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$181K Sell
3,200
-1,400
-30% -$75.2K ﹤0.01% 5292
2014
Q2
$245K Buy
4,600
+1,700
+59% +$90.2K ﹤0.01% 4939
2014
Q1
$152K Sell
2,900
-200
-6% -$10.1K ﹤0.01% 5505
2013
Q4
$166K Sell
3,100
-9,100
-75% -$470K ﹤0.01% 5503
2013
Q3
$618K Sell
12,200
-18,800
-61% -$957K ﹤0.01% 3894
2013
Q2
$1.6M Buy
+31,000
New +$1.65M ﹤0.01% 2806

Other funds holding SNY

UBS's SNY Position: Q3 2014 in Review

UBS reduced its Sanofi (SNY) stake by 1.7% in Q3 2014, selling an estimated $1.02M and leaving 1,076,236 shares worth $60.7M. The position accounts for 0.04% of the portfolio, ranked #432.

UBS first reported a position in SNY in Q2 2013 and has held it in 6 quarters since. The position peaked at $226M in Q4 2013. 502 funds tracked by Wall St. Rank hold SNY as of Q3 2014.

  • UBS held 1,076,236 shares of Sanofi worth $60.7M as of Q3 2014.
  • UBS sold 19,034 Sanofi shares in Q3 2014, an estimated $1.02M.
  • Sanofi made up 0.04% of UBS's portfolio in Q3 2014, its #432 holding.
  • UBS first reported a position in Sanofi in Q2 2013 and has held it in 6 quarters since.
  • UBS's Sanofi position peaked at $226M in Q4 2013.
  • 502 funds tracked by Wall St. Rank held Sanofi as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.